Read-Gene S.A. (WSE:RDG)
4.290
0.00 (0.00%)
At close: Apr 3, 2025, 4:50 PM CET
Read-Gene Revenue
In the year 2024, Read-Gene had annual revenue of 12.85M PLN with 26.62% growth. Read-Gene had revenue of 4.24M in the quarter ending December 31, 2024, a decrease of -0.42%.
Revenue
12.85M
Revenue Growth
+26.62%
P/S Ratio
3.94
Revenue / Employee
584.08K
Employees
22
Market Cap
50.58M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.85M | 2.70M | 26.62% |
Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
Dec 31, 2020 | 6.07M | -296.62K | -4.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.61B |
Synektik Spólka Akcyjna | 556.63M |
Voxel | 492.41M |
Celon Pharma | 209.54M |
Selvita | 345.76M |
Ryvu Therapeutics | 101.96M |
Centrum Medyczne ENEL-MED | 680.32M |
Scope Fluidics | 119.00K |